NN7999-4031: A Non-Interventional Post-Authorisation Safety Study (PASS) in male haemophilia B patients receiving Nonacog Beta Pegol (N9-GP) prophylaxis treatment

27/11/2018
02/07/2024
EU PAS number:
EUPAS26592
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

4031-protocol-eu-pas-reg-redacted

English (426.11 KB - PDF) View document
Updated protocol

4031-protocol-eu-pas-reg-redacted-version-2.0

First published: 22/02/2024
English (458.26 KB - PDF) View document
Study results
Study report
Study report

4031 regulatory progress report pass progress report no.04 eu-pas-reg redacted

English (429.16 KB - PDF) View document

4031-eu-pass-progress-report-20191206

English (102.31 KB - PDF) View document

4031EU pass progress report no.02

English (349.97 KB - PDF) View document

_ Public Registration of Results Regulatory pass progress report redacted

English (315.53 KB - PDF) View document
Other information
Study, other information

4031-eu-pass-progress-report-20191206.pdf

English (102.31 KB - PDF) View document

4031EU pass progress report no.02.pdf

English (349.97 KB - PDF) View document

_ Public Registration of Results Regulatory pass progress report redacted.pdf

English (315.53 KB - PDF) View document